Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/15514097

Download in:

View as

General Info

PMID
15514097